symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ABSI,1.48,1.314731,368334,137212280,0,1.13-3.71,0.05,Absci Corporation,USD,0001672688,US00091E1091,00091E109,NASDAQ Global Select,NASDAQ,Biotechnology,https://www.absci.com,"Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.",Mr. Sean  McClain,Healthcare,US,193,360 949 1041,18105 SE Mill Plain Boulevard,Vancouver,WA,98683,,0,https://financialmodelingprep.com/image-stock/ABSI.png,2021-07-22,False,False,True,False,False
